Beijing Tiantan Biological Products Corporation Limited provided earnings guidance for the first quarter of 2016. For the quarter, the company predicts that it will suffer a loss in its business performance, with its net loss owned by shareholders of listed company to be about RMB 0.7 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.34 CNY | -0.14% | -0.56% | -8.40% |
05-16 | Bank of China Executive Vice President Steps Down | MT |
05-02 | ICBC, CCB Name Deputy Party Secretaries | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.40% | 6.45B | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B |
- Stock Market
- Equities
- 600161 Stock
- News Beijing Tiantan Biological Products Co., Ltd.
- Beijing Tiantan Biological Products Corporation Limited Provides Earnings Guidance for the First Quarter of 2016